Acquisition of Mallinckrodt's contrast media and delivery systems business
Guerbet announced today that it has entered into a definitive agreement under which it will acquire Mallinckrodt’s contrast media and delivery systems business (“CMDS”). With this acquisition, Guerbet aims to create a new global leader in medical imaging.
The pro forma combined sales of Guerbet and the CMDS business were close to €800M in 2014 with a global workforce of around 2,500.
Read the press release
Follow all Guerbet's news on social media ӏ ӏ ӏ ӏ